Cannabidiol Market Report 2026

Cannabidiol Market Overview

• Cannabidiol market size has reached to $15.44 billion in 2025 • Expected to grow to $62.61 billion in 2030 at a compound annual growth rate (CAGR) of 32.5% • Growth Driver: Rise In Neurological Disorders • Market Trend: Innovative Launch Of Non-Psychotropic Cannabidiol For Epilepsy Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cannabidiol Market?

The cannabidiol is defined as a chemical compound found in hemp or marijuana. Cannabidiol or CBD is derived from the Cannabis Sativa plant that is also known as hemp or cannabis. Cannabidiol is used to treat epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and various other health problems. Its other applications include coffee products, skincare products, and pet treats. The main product types of cannabidiol are oil, tinctures, suppository, transdermal patches, vape oil, isolates, creams and roll-on, capsules, tablets, and other products. CBD oil is created by extracting CBD from cannabis plants and diluting it with a carrier oil such as coconut or hemp seed oil. The source of these is marijuana and hemp used as CBD oil and supplements. The applications of these are medical, personal use, pharmaceuticals, and wellness and can be distributed across various channels such as hospital pharmacies, retail pharmacies, online stores, and other distribution channels.

What Is The Cannabidiol Market Growth Forecast?

The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $62.61 billion in 2030 at a compound annual growth rate (CAGR) of 32.5%. The growth in the forecast period can be attributed to increasing acceptance of cbd in healthcare, rising investments in cannabinoid research, expansion of regulated cbd retail channels, growing demand for plant-based therapeutics, increasing standardization of cbd formulations. Major trends in the forecast period include increasing adoption of cbd-based therapeutics, rising demand for wellness and nutraceutical products, growing use in personal care formulations, expansion of pharmaceutical-grade cbd products, enhanced focus on regulatory compliance.

Global Cannabidiol Market Segmentation

1) By Product: Oil, Tinctures, Suppository, Transdermal Patches, Vape Oil, Isolates, Creams and Roll-on, Capsules, Tablet, Other Products 2) By Source: Marijuana, Hemp 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Other Distribution Channels 4) By Application: Medical, Personal Use, Pharmaceuticals, Wellness Subsegments: 1) By Oil: Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate Oil 2) By Tinctures: CBD Tinctures with Flavoring, Unflavored CBD Tinctures 3) By Suppository: Rectal Suppositories, Vaginal Suppositories 4) By Transdermal Patches: CBD Patches for Pain Relief, CBD Patches for Sleep 5) By Vape Oil: CBD Vape Cartridges, CBD Vape Juice 6) By Isolates: CBD Powder, CBD Crystals 7) By Creams and Roll-on: Topical CBD Creams, CBD Roll-on Gels 8) By Capsules: Softgel Capsules, Hard Capsules 9) By Tablet: CBD Tablets, CBD Chewable Tablets 10) By Other Products: Gummies, Beverages, Edibles

What Is The Driver Of The Cannabidiol Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the cannabidiol market going forward. The neurological disorder is a medical condition affecting the central and peripheral nervous systems. It involves the spinal cord, the body's nerves, and the brain. These conditions of neuro are cured by cannabis, which helps in treating neurological conditions by controlling calcium homeostasis and lessening neuroinflammation. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the cannabidiol industry.

What Is The Driver Of The Cannabidiol Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the cannabidiol market going forward. The neurological disorder is a medical condition affecting the central and peripheral nervous systems. It involves the spinal cord, the body's nerves, and the brain. These conditions of neuro are cured by cannabis, which helps in treating neurological conditions by controlling calcium homeostasis and lessening neuroinflammation. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the cannabidiol industry.

Global Cannabidiol Market Trends and Insights

Major companies operating in the cannabidiol market are focusing on developing product innovation, such as epilepsy therapeutic launch to enhance seizure management. Epilepsy therapeutic launch refers to the official introduction or market entry of a pharmaceutical drug specifically developed to prevent, control, or treat epilepsy, aiming to improve seizure management and patient outcomes. For instance, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for the treatment of epilepsy. A new DCGI-approved prescription cannabidiol has been launched in India to help manage seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring its non-psychotropic nature. Clinical studies indicate its effectiveness in reducing seizures, particularly when traditional antiseizure medications are ineffective.

What Are Latest Mergers And Acquisitions In The Cannabidiol Market?

In April 2025, Xebra Brands Ltd., a Canada‑based CBD products company, acquired a 100% stake in BSK Holdings Inc. for an undisclosed amount. With this acquisition, Xebra aimed to expand its footprint into the U.S. CBD market and accelerate entry into North America’s largest hemp/CBD market. BSK Holdings Inc. is a US-based CBD company specializing in e-commerce sales of premium CBD products, including top-selling brands like Keoni and AMMA in the US market.

Regional Insights

North America was the largest region in the cannabidiol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cannabidiol Market?

The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cannabidiol Market Report 2026?

The cannabidiol market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.